Jerrell Shelton - 31 Jul 2025 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Signature
/s/ Jerrell Shelton
Issuer symbol
CYRX
Transactions as of
31 Jul 2025
Net transactions value
+$125,000
Form type
4
Filing time
04 Aug 2025, 18:00:17 UTC
Previous filing
28 Jul 2025
Next filing
15 Aug 2025

Quoteable Key Fact

"Jerrell Shelton filed Form 4 for Cryoport, Inc. (CYRX) on 04 Aug 2025."

Quick Takeaways

  • This page summarizes Jerrell Shelton's Form 4 filing for Cryoport, Inc. (CYRX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Filing timestamp: 04 Aug 2025, 18:00.

What Changed

  • Previous filing in this sequence was filed on 28 Jul 2025.
  • Current net transaction value: +$125,000.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SHELTON JERRELL President, CEO, Director C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD /s/ Jerrell Shelton 04 Aug 2025 0001283212

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise $125,000 +25,000 +2.5% $5.00 1,037,419 31 Jul 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Stock Option (right to buy) Options Exercise $0 -25,000 -50% $0.000000 25,000 31 Jul 2025 Common Stock 25,000 $5.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
F2 1/48 of the options vested on the 19th of each month for forty-eight months beginning on 8/19/2015.